Aflac Incorporated to Release Fourth Quarter Results and CFO Video Update on February 4, 2026 and Host Webcast on February 5, 2026

Aflac Incorporated (NYSE: AFL), a prominent player in the supplemental health insurance sector, has announced its plans to release fourth quarter financial results for 2025 after market close on February 4, 2026. Accompanying this release will be access to a financial update video presented by Senior Executive Vice President and Chief Financial Officer Max Brodén on the company's Investor Relations website.

The company will also hold a conference call at 8:00 a.m. Eastern Time on February 5, 2026, where key executives, including Chairman and CEO Daniel P. Amos and President Virgil Miller, will discuss the quarterly results and address questions from investors. Participants are encouraged to register on the Investor Relations website five to seven minutes in advance of the call.

Aflac has a strong legacy of providing financial protection to millions of policyholders, primarily through its subsidiaries in the U.S. and Japan. It holds a leading position in supplemental health insurance in the U.S. and is recognized in Japan for its substantial market share in cancer and medical insurance. The company's commitment to its policyholders and ethical practices is evident; it has been recognized among the World's Most Ethical Companies by Ethisphere for 19 years and rated as one of Fortune's Most Admired Companies for 24 consecutive years.

Furthermore, Aflac’s commitment to sustainability is highlighted through its participation in the Principles for Responsible Investment (PRI) since 2021 and inclusion in the Dow Jones Sustainability North America Index for 11 years. Investors can find more information about Aflac’s financial performance and corporate social responsibility efforts on its dedicated Investor Relations page.

As Aflac Incorporated (NYSE: AFL) prepares to release its fourth-quarter 2025 financial results and host an accompanying CFO video update on February 4, 2026, with a follow-up webcast on February 5, stakeholders should approach these events with a strategic mindset. Historically, Aflac has showcased resilience and adaptability in its operations, particularly in its dual-market approach in the U.S. and Japan. This diversification could prove advantageous in the current economic climate, marked by inflationary pressures and varied healthcare costs.

Analysts anticipate that the fourth-quarter results will reflect Aflac's commitment to robust financial performance, considering its long-standing reputation. The company's leadership, including CEO Daniel P. Amos and CFO Max Brodén, will likely provide insights into strategic initiatives and operational efficiencies that have influenced quarter-over-quarter growth. Investors should listen closely for updates on premium growth in both the U.S. and Japan, particularly in supplemental health insurance—a sector Aflac leads in the U.S.

Moreover, given Aflac’s inclusion in the Dow Jones Sustainability North America Index, emphasis on corporate social responsibility may also be a focal point, appealing to ethical investors. Aflac's commitment to supporting policyholders during financial hardships presents a strong case for the company’s resilience and ethical standing, which could attract ESG-focused investment.

Investors looking to capitalize on the earnings call should consider registering early to engage with management and gain insights into competitive strategies and future forecasts. Depending on the outcomes presented during these announcements, those holding Aflac shares may need to evaluate their positions—especially if the reports offer unexpected results or outlooks.

In summary, as Aflac approaches this pivotal moment, the potential for stability and growth remains promising, making it crucial for investors to stay informed and prepared to act based on the insights revealed in the upcoming financial updates.